tau-targeting – Talk Bio

Actionable Insights Powered by AI

Sanofi Licenses ADEL’s Tau-Targeting Alzheimer’s Drug for $1.04 Billion Deal Including $80M Upfront

9 hours ago talkbio0Tagged ADEL, Alzheimer 's, sanofi, tau-targeting

Sanofi; ADEL; Alzheimer’s; tau-targeting; licensing deal; biotech